These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2671919)

  • 21. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol.
    Hodson EM; Evans RA; Dunstan CR; Hills E; Wong SY; Rosenberg AR; Roy LP
    Clin Nephrol; 1985 Oct; 24(4):192-200. PubMed ID: 3877585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of calcium and phosphorus metabolism disorders with vitamin D metabolites. Preliminary results].
    Vuković D; Stojanov LJ; Banićević M; Bogdanović R
    Srp Arh Celok Lek; 1980 Sep; 108(9):909-21. PubMed ID: 6895421
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New developments in the vitamin D endocrine system.
    DeLuca HF
    J Am Diet Assoc; 1982 Mar; 80(3):231-7. PubMed ID: 6895759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anomalies of phosphorus-calcium metabolism in renal insufficiency. Value of the physiopathological diagnosis and therapy].
    Hioco D; Dorfmann H; Chot ST; Bordier P; de Zèze S
    Rev Rhum Mal Osteoartic; 1972 Oct; 39(10):617-25. PubMed ID: 5083698
    [No Abstract]   [Full Text] [Related]  

  • 29. [Calcium and phosphrous evaluation during cortisone treatment of nephrotic syndrome in relapse].
    Belon C; Dumas R; Jean R; Huguet R
    Arch Fr Pediatr; 1979 Dec; 36(10):1006-12. PubMed ID: 317636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [1 alpha-hydroxycholecalciferol in treatment of renal osteodystrophy].
    Chalmers TM; Davie MW; Hunter JO; Szaz KF
    J Urol Nephrol (Paris); 1974 Dec; 80(12):981. PubMed ID: 4617778
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal hypophosphatemic rickets - a review.
    Chan JC
    Int J Pediatr Nephrol; 1982 Dec; 3(4):305-10. PubMed ID: 6762360
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical picture, diagnosis and therapy of renal osteodystrophy].
    Bombor H
    Z Urol Nephrol; 1977 Aug; 70(8):603-7. PubMed ID: 335702
    [No Abstract]   [Full Text] [Related]  

  • 35. 11. Vitamin D in the therapy of disorders of calcium and phosphorus metabolism.
    Kumar R; Riggs BL
    Mayo Clin Proc; 1981 May; 56(5):327-33. PubMed ID: 6262583
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progression of hyperparathyroidism during hemodialysis. Response to conservative treatment].
    García de Vinuesa S; Luño J; González C; Resano M; Allés A; Olivas E; Barril G; Valderrábano F
    Rev Clin Esp; 1982 Feb; 164(3):163-7. PubMed ID: 6896386
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of 1,25-dihydroxyvitamin D3 in early renal failure.
    Goodman WG; Coburn JW
    Annu Rev Med; 1992; 43():227-37. PubMed ID: 1580587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
    Sjödén G
    Acta Orthop Scand Suppl; 1985; 217():1-84. PubMed ID: 3911723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy with vitamin D and D-metabolites].
    Flury W; Haldimann B
    Schweiz Med Wochenschr; 1981 Feb; 111(9):314-21. PubMed ID: 6261326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.